THC Farmaceuticals, Inc. announced that it will issue minimum of 20,000 common shares and maximum of 248,000 common shares at a price of $0.5 per share for minimum gross proceeds of $10,000 and maximum gross proceeds of $124,000 on February 8, 2023. The common shares have voting rights. The company will raise funding through crowdfunding platform ChainRaise Portal LLC.

The company will pay minimum fees of $500, and maximum fees of $6,200 to ChainRaise Portal LLC. The company will raise minimum net proceeds of $9,500, and maximum net proceeds of $117,800 in the transaction. The minimum investment accepted from any outside investor is $500.

The round is raised at a pre-money valuation of $9,000,000. The company will accept oversubscriptions in the transaction. The company will issue securities pursuant to exemptions provided under Regulation CF.

All securities to be issued will be subject to transfer restrictions for a period of one year. The company expects to close the transaction on February 7, 2024.